Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v5-FR
Language French French
Date Updated 2018-07-31 2017-12-12
Drug Identification Number 02343681 02343681
Brand name OLANZAPINE ODT OLANZAPINE ODT
Common or Proper name OLANZAPINE ODT OLANZAPINE ODT
Company Name SIVEM PHARMACEUTICALS ULC SIVEM PHARMACEUTICALS ULC
Ingredients OLANZAPINE OLANZAPINE
Strength(s) 15MG 15MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size 30 30
ATC code N05AH N05AH
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2017-12-25 2017-12-25
Actual start date 2017-12-04
Estimated end date Unknown
Actual end date 2018-07-02
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Temporarily unavaible
Health Canada comments